Pharmaceutical Combination comprising (i) a least a receptor antagonist Selected 1-3 of VEGFR, PDGFR Alpha and beta, FGFR1 3, EGFR, HER2, IGF1R, HGFR or C - Kit,And (ii) at least one chemotherapeutic agent or therapeutic use in the treatment and

摘要

The present Invention relates to a Pharmaceutical composition for the treatment of diseases involving Cell migration or apoptosis of Myeloma cells or angiogenesis.The Invention also relates to a method for the treatment of such diseases comprising the Administration of effective amounts of specific compounds and / orCo Treatment with Radiation Therapy, in a relationship which provides a synergistic or additive effect.And the combined use of these specific compounds and / or radiation therapy for the manufacture of pharmaceutical preparations for combinations.